{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:24:18Z","timestamp":1782840258552,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13104-019-4548-x","type":"journal-article","created":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T14:02:40Z","timestamp":1565964160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Latent tuberculosis infection and associated risk factors among people living with HIV and apparently healthy blood donors at the University of Gondar referral hospital, Northwest Ethiopia"],"prefix":"10.1186","volume":"12","author":[{"given":"Mekdes","family":"Tilahun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agumas","family":"Shibabaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amare","family":"Kiflie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezahegn","family":"Bewket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebba","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baye","family":"Gelaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,16]]},"reference":[{"issue":"20","key":"4548_CR1","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1056\/NEJMsa031667","volume":"350","author":"J Horsburgh","year":"2004","unstructured":"Horsburgh J. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060\u20137.","journal-title":"N Engl J Med"},{"issue":"11","key":"4548_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","volume":"19","author":"S Lawn","year":"2005","unstructured":"Lawn S, Bekker L, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control. AIDS. 2005;19(11):1113\u201324.","journal-title":"AIDS"},{"issue":"5","key":"4548_CR3","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1164\/ajrccm\/148.5.1292","volume":"148","author":"B Jones","year":"1993","unstructured":"Jones B, Young S, Antoniskis D, Davidson P, Kramer F, Barnes P. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis. 1993;148(5):1292\u20137.","journal-title":"Am Rev Respir Dis"},{"key":"4548_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1471-2334-10-267","volume":"10","author":"A Diaz","year":"2010","unstructured":"Diaz A, Diez M, Bleda M, Aldamiz M, Camafort M, Camino X, Cepeda C, Costa A, Ferrero O, Geijo P. Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain. BMC Infect Dis. 2010;10:267.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4548_CR5","first-page":"427","volume":"1","author":"H Yanai","year":"1997","unstructured":"Yanai H, Uthaivoravit W, Mastro T, Limpakarnjanarat K, Sawanpanyalert P, Morrow J, Nieburg P. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand. Int J Tuberc Lung Dis. 1997;1(5):427\u201334.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"4548_CR6","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1378\/chest.08-2575","volume":"136","author":"L Richeldi","year":"2009","unstructured":"Richeldi L, Losi M, D\u2019Amico R, Luppi M, Ferrari A, Mussini C, Codeluppi M, Cocchi S, Prati F, Paci V. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest J. 2009;136(1):198\u2013204.","journal-title":"Chest J"},{"issue":"5","key":"4548_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","volume":"175","author":"M Rangaka","year":"2007","unstructured":"Rangaka M, Wilkinson K, Seldon R, Van Cutsem G, Meintjes G, Morroni C, Mouton P, Diwakar L, Connell T, Maartens G. Effect of HIV-1 infection on T-cell-based and skin test detection of tuberculosis infection. Am J Respir Crit Care Med. 2007;175(5):514\u201320.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"4548_CR8","doi-asserted-by":"publisher","first-page":"e64008","DOI":"10.1371\/journal.pone.0064008","volume":"8","author":"A Jensen","year":"2013","unstructured":"Jensen A, Jensen L, Faurholt-Jepsen D, Aabye M, Praygod G, Kidola J, Faurholt-Jepsen M, Changalucha J, Range N, Krarup H. The prevalence of latent Mycobacterium tuberculosis infection based on an interferon-\u03b3 release assay: a cross-sectional survey among urban adults in Mwanza, Tanzania. PLoS ONE. 2013;8(5):e64008.","journal-title":"PLoS ONE"},{"issue":"1","key":"4548_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-2334-11-89","volume":"11","author":"M Legesse","year":"2011","unstructured":"Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, Abebe F. Community-based cross-sectional survey of latent tuberculosis infection in Afar pastoralists, Ethiopia, using QuantiFERON-TB Gold In-Tube and tuberculin skin test. BMC Infect Dis. 2011;11(1):89.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"4548_CR10","doi-asserted-by":"publisher","first-page":"e0141511","DOI":"10.1371\/journal.pone.0141511","volume":"10","author":"C Chen","year":"2015","unstructured":"Chen C, Zhu T, Wang Z, Peng H, Kong W, Zhou Y, Shao Y, Zhu L, Lu W. High latent TB infection rate and associated risk factors in the Eastern China of low TB incidence. PLoS ONE. 2015;10(10):e0141511.","journal-title":"PLoS ONE"},{"key":"4548_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.tbtb2-0023-2016","author":"M Pai","year":"2016","unstructured":"Pai M, Behr M. Latent Mycobacterium tuberculosis infection and interferon-gamma release assays. Microbiol Spectr. 2016. \n                    https:\/\/doi.org\/10.1128\/microbiolspec.tbtb2-0023-2016\n                    \n                  .","journal-title":"Microbiol Spectr"},{"issue":"6","key":"4548_CR12","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","volume":"46","author":"H Getahun","year":"2015","unstructured":"Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Gutierrez SMB, Bruchfeld J, Burhan E. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015;46(6):1563\u201376.","journal-title":"Eur Respir J"},{"issue":"4","key":"4548_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1164\/rccm.201209-1621CI","volume":"188","author":"Gil Redelman-Sidi","year":"2013","unstructured":"Redelman-Sidi Gil, Sepkowitz Kent A. IFN-\u03b3 release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med. 2013;188(4):422\u201331.","journal-title":"Am J Respir Crit Care Med"},{"key":"4548_CR14","volume-title":"Guide to monitoring and evaluation for collaborative TB\/HIV activities\u20132015 update","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Guide to monitoring and evaluation for collaborative TB\/HIV activities\u20132015 update. Geneva: World Health Organization; 2015."},{"issue":"4","key":"4548_CR15","doi-asserted-by":"publisher","first-page":"e95828","DOI":"10.1371\/journal.pone.0095828","volume":"9","author":"I Coimbra","year":"2014","unstructured":"Coimbra I, Maruza M, Albuquerque MdFPM, Batista JDAL, Braga MC, Moura LV, Miranda-Filho DB, Montarroyos UR, Lacerda HR, Rodrigues LC. Validating a scoring system for the diagnosis of smear-negative pulmonary tuberculosis in HIV-infected adults. PLoS ONE. 2014;9(4):e95828.","journal-title":"PLoS ONE"},{"key":"4548_CR16","volume-title":"Global tuberculosis report","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Global tuberculosis report. Geneva: World Health Organization; 2015."},{"key":"4548_CR17","doi-asserted-by":"crossref","unstructured":"Wong NS, Leung CC, Chan KCW, Chan WK, Lin AWC, Lee SS. A longitudinal study on latent TB infection screening and its association with TB incidence in HIV patients. Scientific Rep. 9, Article number: 10093; 2019.","DOI":"10.1038\/s41598-019-46570-5"},{"issue":"3","key":"4548_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4314\/ahs.v15i3.20","volume":"15","author":"D Mumpe-Mwanja","year":"2015","unstructured":"Mumpe-Mwanja D, Verver S, Yeka A, Etwom A, Waako J, Ssengooba W, Matovu J, Wanyenze R, Musoke P, Mayanja-Kizza H. Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern Uganda. Afr Health Sci. 2015;15(3):851\u201360.","journal-title":"Afr Health Sci"},{"issue":"1","key":"4548_CR19","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/1471-2334-10-348","volume":"10","author":"I Latorre","year":"2010","unstructured":"Latorre I, Mart\u00ednez-Lacasa X, Font R, Lacoma A, Puig J, Tural C, Lite J, Prat C, Cuchi E, Ausina V. IFN-\u03b3 response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection. BMC Infect Dis. 2010;10(1):348.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"4548_CR20","doi-asserted-by":"publisher","first-page":"e18206","DOI":"10.1371\/journal.pone.0018206","volume":"6","author":"K Shanaube","year":"2011","unstructured":"Shanaube K, Hargreaves J, Fielding K, Schaap A, Lawrence K, Hensen B, Sismanidis C, Menezes A, Beyers N, Ayles H. Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa. PLoS ONE. 2011;6(4):e18206.","journal-title":"PLoS ONE"},{"issue":"1","key":"4548_CR21","first-page":"10","volume":"4","author":"H Mohamed","year":"2016","unstructured":"Mohamed H, Alothman A, Baffoe-Bonnie H, Alageeb H. What is the rate of latent tuberculosis infection in human immunodeficiency virus (HIV) infected patients in Saudi Arabia? Am J Epidemiol Infect Dis. 2016;4(1):10\u20133.","journal-title":"Am J Epidemiol Infect Dis"},{"key":"4548_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1471-2334-12-107","volume":"12","author":"M Kall","year":"2012","unstructured":"Kall M, Coyne K, Garrett N, Boyd A, Ashcroft A, Reeves I, Anderson J, Bothamley G. Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study. BMC Infect Dis. 2012;12:107.","journal-title":"BMC Infect Dis"},{"key":"4548_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2334-9-15","volume":"9","author":"N Talati","year":"2009","unstructured":"Talati N, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, Albalak R, Blumberg H. Poor concordance between interferon-\u03b3 release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis. 2009;9:15.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"4548_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1086\/318081","volume":"183","author":"A Lalvani","year":"2001","unstructured":"Lalvani A, Nagvenkar P, Udwadia Z, Pathan A, Wilkinson K, Shastri J, Ewer K, Hill A, Mehta A, Rodrigues C. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis. 2001;183(3):469\u201377.","journal-title":"J Infect Dis"},{"issue":"9323","key":"4548_CR25","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","volume":"359","author":"M Badri","year":"2002","unstructured":"Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002;359(9323):2059\u201364.","journal-title":"Lancet"},{"issue":"4","key":"4548_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1086\/338641","volume":"34","author":"G Santoro-Lopes","year":"2002","unstructured":"Santoro-Lopes G, de Pinho A, Harrison L, Schechter M. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy. Clin Infect Dis. 2002;34(4):543\u20136.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"4548_CR27","first-page":"1026","volume":"4","author":"J Jones","year":"2000","unstructured":"Jones J, Hanson D, Dworkin M, DeCock K, Adult\/Adolescent Spectrum of HIV Disease Group. HIV-associated tuberculosis in the era of highly active antiretroviral therapy The Adult\/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis. 2000;4(11):1026\u201331.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"4548_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.5588\/ijtld.10.0483","volume":"15","author":"S Lawn","year":"2011","unstructured":"Lawn S, Harries A, Williams B, Chaisson R, Losina E, De Cock K, et al. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis. 2011;15(5):571\u201381.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"4548_CR29","doi-asserted-by":"publisher","first-page":"e0135801","DOI":"10.1371\/journal.pone.0135801","volume":"10","author":"S Lee","year":"2015","unstructured":"Lee S, Lin H, Tsai H, Su I, Yang C, Sun H, Hung C, Sy C, Wu K, Chen J. A clinical algorithm to identify HIV patients at high risk for incident active tuberculosis: a prospective 5-year cohort study. PLoS ONE. 2015;10(8):e0135801.","journal-title":"PLoS ONE"},{"issue":"8","key":"4548_CR30","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1093\/aje\/kwu192","volume":"180","author":"J Zelner","year":"2014","unstructured":"Zelner J, Murray M, Becerra M, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Grenfell B. Age-specific risks of tuberculosis infection from household and community exposures and opportunities for interventions in a high-burden setting. Am J Epidemiol. 2014;180(8):853\u201361.","journal-title":"Am J Epidemiol"},{"key":"4548_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141511","author":"C Cheng","year":"2015","unstructured":"Cheng C, Tao Z, Zhijian W, Hong P, Wen K, Yang Z, Yan S, Limei Z, Wei L. High latent Tb infection rate and associated risk factors in the eastern china of low TB incidence. PLoS ONE. 2015. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0141511\n                    \n                  .","journal-title":"PLoS ONE"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4548-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4548-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4548-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T23:13:36Z","timestamp":1597446816000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4548-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,16]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4548"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4548-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,16]]},"assertion":[{"value":"26 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from the School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, the University of Gondar, Ethical Review Committee. A written informed consent was obtained from each study participant. The laboratory results were communicated to their attending physicians for appropriate treatment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"In this study, no individual details, images or videos were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"515"}}